BMC Pregnancy Childbirth
October 2024
Background: The prostaglandin E1 analog "misoprostol" is a drug that has powerful ecbolic effects and can be beneficial in the prevention and treatment of postpartum hemorrhage, which is the leading cause of maternal mortality worldwide.
Objectives: To assess the value of adding intrauterine misoprostol together with intravenous oxytocin injection compared with sublingual misoprostol together with intravenous oxytocin injection during elective cesarean section to reduce blood loss intraoperatively and prevent postpartum hemorrhage.
Methods: A total of 192 pregnant women were counseled and recruited from the labor and delivery unit at Kasr Al Aini Hospital, Cairo University, and equally randomized into two groups.
Objective: To compare the ICSI-ET outcomes in patients with endometriosis with or without laser-assisted zona pellucida thinning.
Design: Randomized controlled trial.
Setting: The study was conducted in the Obstetrics & Gynecology Department, Cairo University hospital, and two private IVF centers in Cairo & Beni-Suif from July 2015 to January 2017 upon infertile and known endometriosis patients who planned to do ICSI-ET.
Objective: To evaluate the efficacy of a dry versus humidified incubator on human embryo development ex vivo.
Design: Prospective, double-blind, randomized, controlled trial.
Setting: Private fertility centers.